Evidence map›Paper›PMID 23747485›Full record

ArticleJournal of molecular biology2013

Molecular mechanism of membrane binding of the GRP1 PH domain.

Chun-Liang Lai, Anand Srivastava, Carissa Pilling, Anna R Chase, Joseph J Falke, Gregory A Voth

Abstract read
In one paragraph

Article in Journal of molecular biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Two-step mechanism of Bruton's tyrosine kinase membrane recruitment and activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Lysosomal PIPProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  7. Review
  8. Article
  9. Cooperative Membrane Binding of HIV-1 Matrix Proteins.The journal of physical chemistry. B · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Binding of CaStructure (London, England : 1993) · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chun-Liang LaiDepartment of Chemistry, Institute of Biophysical Dynamics, James Franck Institute, and Computation Institute, University of Chicago, Chicago, IL 60637, USA.
Anand Srivastava
Carissa Pilling
Anna R Chase
Joseph J Falke
Gregory A Voth

Funding

Mechanisms of Signaling on Membrane SurfacesR01GM063235 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2001 to 2021
$6.4M
New Method for Biomembrane SimulationsR01GM063796 · NIGMS · UNIVERSITY OF UTAH · PI VOTH, GREGORY A. · 2001 to 2025
$6.3M
NIGMS NIH HHS R01 GM063235NIGMS NIH HHS R01-GM063235NIGMS NIH HHS R01 GM063796NIGMS NIH HHS R01-GM063796
6 · The paper itself

Abstract

The pleckstrin homology (PH) domain of the general receptor of phosphoinositides 1 (GRP1) protein selectively binds to a rare signaling phospholipid, phosphatidylinositol (3,4,5)-trisphosphate (PIP3), in the membrane. The specific PIP3 lipid docking of GRP1 PH domain is essential to protein cellular function and is believed to occur in a stepwise process, electrostatic-driven membrane association followed by the specific PIP3 binding. By a combination of all-atom molecular dynamics (MD) simulations, coarse-grained analysis, electron paramagnetic resonance (EPR) membrane docking geometry, and fluorescence resonance energy transfer (FRET) kinetic studies, we have investigated the search and bind process in the GRP1 PH domain at the molecular scale. We simulated the two membrane binding states of the GRP1 PH domain in the PIP3 search process, before and after the GRP1 PH domain docks with the PIP3 lipid. Our results suggest that the background anionic phosphatidylserine lipids, which constitute around one-fifth of the membrane by composition, play a critical role in the initial stages of recruiting protein to the membrane surface through non-specific electrostatic interactions. Our data also reveal a previously unseen transient membrane association mechanism that is proposed to enable a two-dimensional "hopping" search of the membrane surface for the rare PIP3 target lipid. We further modeled the PIP3-bound membrane-protein system using the EPR membrane docking structure for the MD simulations, quantitatively validating the EPR membrane docking structure and augmenting our understanding of the binding interface with atomic-level detail. Several observations and hypotheses reached from our MD simulations are also supported by experimental kinetic studies.

Indexed as

Blood ProteinsCell MembraneKineticsLipid BilayersMembrane ProteinsModels, MolecularMolecular Dynamics SimulationPhosphatidylinositol PhosphatesPhosphatidylserinesPhospholipidsPhosphoproteinsProtein BindingProtein Structure, TertiaryReceptors, Cytoplasmic and NuclearStatic ElectricityBlood ProteinsLipid BilayersMembrane ProteinsPhosphatidylinositol Phosphatesphosphatidylinositol receptorsPhosphatidylserinesPhospholipidsPhosphoproteinsplatelet protein P47Receptors, Cytoplasmic and Nuclearanionic lipidsCGcoarse-grainedelectron paramagnetic resonanceENTHEPREpsin N-terminal homologyfluorescence resonance energy transferFRETgeneral receptor of phosphoinositides 1GRP1MDmembrane targetingmolecular dynamicsPDBperipheral membrane proteinPHphosphatidylinositol (3,4,5)-trisphosphatephosphatidylinositol-3,4,5-trisphosphate or PIP(3)phosphatidylinositol (4,5)-bisphosphatephosphatidylserinePIP(2)PIP(3)pleckstrin homologypleckstrin homology domainProtein Data BankPSRMSFroot-mean-square fluctuation

Identifiers

PMID23747485
PMCPMC4265004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.